Fujifilm Acquires the Digital Pathology Technology Assets of Inspirata

Fujifilm Acquires the Digital Pathology Technology Assets of Inspirata

Fujifilm has acquired the digital pathology technology assets of Inspirata. The digital pathology offerings, customers and employees of Inspirata will move to Fujifilm. Terms of the deal were not disclosed. Inspirata’s Dynamyx is an end-to-end digital pathology solution using whole-slide images to digitize patient results. The software capabilities are typically implemented within more extensive medical facilities handling large volumes of pathological images across several lab locations. Japan-based Fujifilm provides imaging, information and document solutions. According to the LevinPro HC database, this was the 128th Laboratories, MRI and Dialysis deal of 2022, This compares with... Read More »
Olympus Corporation Acquires Odin Vision

Olympus Corporation Acquires Odin Vision

Olympus Corporation announced its agreement to acquire cloud-based AI endoscopy technology developer Odin Vision. The agreement totals up to $79 million in upfront and milestone-based payments. The acquisition constitutes a strategic component of Olympus’ broader aim to transform clinical and procedural workflows. Terms of the deal were not disclosed. London-based Odin Vision develops a portfolio of commercially available computer-aided detection/diagnostic solutions. It also holds an innovation pipeline of cloud-enabled applications. Olympus uses innovative capabilities in medical technology, therapeutic intervention and precision manufacturing to help healthcare professionals deliver... Read More »
​​Anne Arundel Dermatology Acquires Two Dermatology Clinics and One Dermatology Laboratory

​​Anne Arundel Dermatology Acquires Two Dermatology Clinics and One Dermatology Laboratory

Anne Arundel Dermatology Management (ADM) announced on December 14 that it purchased North Atlanta Dermatology and Dermatology Institute for Skin Cancer & Cosmetic Surgery, as well as the dermatology laboratory, SkinPath Solutions. ADM, a portfolio company of Ridgemont Equity Partners, is the largest dermatology provider in Maryland, with 19 locations and more than 35 providers offering general dermatology, advanced skin cancer treatments and cosmetic procedures. SkinPath Solutions is a privately owned, independent laboratory specializing in the diagnosis of skin, hair and nail disorders of all types. SkinPath serves clients across the Southeast with dermatopathologists licensed in... Read More »
Bionano Genomics Acquires Purigen Biosystems for up to $64 Million

Bionano Genomics Acquires Purigen Biosystems for up to $64 Million

Bionano Genomics has acquired Purigen Biosystems in a deal valued at up to $64 million. This includes $32 million in cash paid at closing subject to adjustment for, among other things, cash, unpaid indebtedness, unpaid transaction expenses and net working capital relative to a specified target. The remainder of the consideration is contingent on the achievement of certain milestones. The deal is expected to close on or before December 8, 2022. Pleasanton, California-based Purigen Biosystems focuses on redefining nucleic acid sample preparation with a platform based on the isotachophoresis technology. Bionano Genomics, which is located in San Diego, provides genome analysis solutions that... Read More »
Bionano Genomics Acquires Purigen Biosystems for up to $64 Million

Cambrex Acquires Snapdragon Chemistry

East Rutherford, New Jersey-based Cambrex Corporation has acquired Snapdragon Chemistry of Waltham, Massachusetts. Snapdragon specializes in active pharmaceutical ingredient (API) batch and continuous flow process development, utilizing automation technology and proprietary equipment to solve complex process and analytical development challenges. Cambrex is a global contract development and manufacturing organization (CDMO) that provides drug substance, drug product and analytical services across the entire drug lifecycle. The transaction is expected to close following the completion of customary regulatory approvals. This will be Cambrex’s second acquisition within a year along with... Read More »
Telix Pharmaceuticals Acquires Optimal Tracers

Telix Pharmaceuticals Acquires Optimal Tracers

Telix Pharmaceuticals Limited has acquired Sacramento, California-based Optimal Tracers. Optimal Tracers is a division of Northern California PET Imaging Center, a not-for-profit business providing clinical and clinical trial imaging services in northern California. Optimal Tracers provides manufacturing and development radiochemistry services in support of academic and pharmaceutical research activities. Telix Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals. Telix is developing a portfolio of radiopharmaceutical products that aims to address significant unmet medical needs in oncology and... Read More »